Literature DB >> 25654058

BOTOX: Broadening the Horizon of Dentistry.

Pranav Nayyar1, Pravin Kumar2, Pallavi Vashisht Nayyar3, Anshdeep Singh4.   

Abstract

Botox has been primarily used in cosmetic treatment for lines and wrinkles on the face, but the botulinum toxin that Botox is derived from has a long history of medically therapeutic uses. For nearly 13 years, until the introduction of Botox Cosmetic in 2002, the only FDA-approved uses of Botox were for crossed eyes (strabismus) and abnormal muscle spasms of the eyelids (blepharospasm). Since then botulinum A, and the seven other forms of the botulinum toxin, have been continuously researched and tested. Botox is a neurotoxin derived from bacterium clostridium botulinm. The toxin inhibits the release of acetylcholine (ACH), a neurotransmitter responsible for the activation of muscle contraction and glandular secretion, and its administration results in reduction of tone in the injected muscle. The use of Botox is a minimally invasive procedure and is showing quite promising results in management of muscle-generated dental diseases like Temporomandibular disorders, bruxism, clenching, masseter hypertrophy and used to treat functional or esthetic dental conditions like deep nasolabial folds, radial lip lines, high lip line and black triangles between teeth.

Entities:  

Keywords:  Black triangles; Botulinum toxin A; Bruxism; Gummy smile; Hyperfunction

Year:  2014        PMID: 25654058      PMCID: PMC4316364          DOI: 10.7860/JCDR/2014/11624.5341

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  30 in total

Review 1.  Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.

Authors:  L Mandel; M Tharakan
Journal:  J Oral Maxillofac Surg       Date:  1999-08       Impact factor: 1.895

2.  Treatment of bruxism with botulinum toxin injections.

Authors:  M Van Zandijcke; M M Marchau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

3.  [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].

Authors:  R Laskawi; S Rohrbach
Journal:  Laryngorhinootologie       Date:  2001-12       Impact factor: 1.057

Review 4.  Application of Botulinum toxin type A: an arsenal in dentistry.

Authors:  Lakshmana B Rao; Rajashekar Sangur; S Pradeep
Journal:  Indian J Dent Res       Date:  2011 May-Jun

5.  [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].

Authors:  B A Rijsdijk; R J van ES; F W Zonneveld; M H Steenks; R Koole
Journal:  Ned Tijdschr Geneeskd       Date:  1998-03-07

6.  The treatment of masseter hypertrophy with botulinum toxin type A.

Authors:  Hazem T Al-Ahmad; Mansour A Al-Qudah
Journal:  Saudi Med J       Date:  2006-03       Impact factor: 1.484

Review 7.  Evidence for antinociceptive activity of botulinum toxin type A in pain management.

Authors:  K Roger Aoki
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

8.  Botulinum toxin in a case of hemimasticatory spasm with severe worsening during pregnancy.

Authors:  María Graciela Cersósimo; Alicia Bertoti; Claudia Uribe Roca; Federico Micheli
Journal:  Clin Neuropharmacol       Date:  2004 Jan-Feb       Impact factor: 1.592

9.  Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment.

Authors:  Young Chang Lim; Eun Chang Choi
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-18       Impact factor: 2.503

Review 10.  Treatment of temporomandibular disorders with botulinum toxin.

Authors:  Marvin Schwartz; Brian Freund
Journal:  Clin J Pain       Date:  2002 Nov-Dec       Impact factor: 3.442

View more
  10 in total

1.  Use of diffusion-weighted imaging in the noninvasive diagnostic of obstructed biliary ducts.

Authors:  Eliane Donato Leite Paro; Andrea Puchnick; Jacob Szejnfeld; Suzan Menasce Goldman
Journal:  Abdom Radiol (NY)       Date:  2020-07-14

2.  Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism.

Authors:  Hatice Hosgor; Sezen Altindis
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-10-31

Review 3.  Applications of botulinum toxin in dentistry: A comprehensive review.

Authors:  Sanjeev Srivastava; Smriti Kharbanda; U S Pal; Vinit Shah
Journal:  Natl J Maxillofac Surg       Date:  2015 Jul-Dec

4.  Treatment of hemifacial spasm in patient with hemifacial atrophy using combination therapy (ultrasound therapy and TENS): a case report.

Authors:  Apala Baduni; Bhuvana Krishnamoorthy
Journal:  Korean J Pain       Date:  2017-09-29

5.  Physicians' Practice of the Non-Cosmetic Uses of Botulinum Toxin: A Cross-Sectional Study in Saudi Arabia.

Authors:  Sarah A Alzarah; Huda Alabasi; Lujain Alanazi; Munirah Aldawsari; Etedal Aldawsari; Shazia Iqbal
Journal:  Cureus       Date:  2022-01-17

Review 6.  Botox and Dermal Fillers in Orthodontics - A Review.

Authors:  Truppti Pavinvhandra Sonone; Vivek Soni; Soumya Gupta; Yash K Shekatkar; Aniket S Thorat; Tejas R Pol
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

Review 7.  Clinical and radiographic features of facial cosmetic materials: A systematic review.

Authors:  Noura Alsufyani; Reem Aldosary; Rasha Alrasheed; Mohammed Alsufyani
Journal:  Imaging Sci Dent       Date:  2022-03-15

8.  Influence of Botulinumtoxin A on the Expression of Adult MyHC Isoforms in the Masticatory Muscles in Dystrophin-Deficient Mice (Mdx-Mice).

Authors:  Ute Ulrike Botzenhart; Constantin Wegenstein; Teodor Todorov; Christiane Kunert-Keil
Journal:  Biomed Res Int       Date:  2016-08-07       Impact factor: 3.411

9.  Consensus Recommendations for Treatment Strategies in Indians Using Botulinum Toxin and Hyaluronic Acid Fillers.

Authors:  Krishan Mohan Kapoor; Vandana Chatrath; Chytra Anand; Rashmi Shetty; Chiranjiv Chhabra; Kuldeep Singh; Maya Vedamurthy; Jamuna Pai; Bindu Sthalekar; Rekha Sheth
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-12-28

10.  Upper Lip Horizontal Line: Characteristics of a Dynamic Facial Line.

Authors:  Alexander D Vardimon; Nir Shpack; Atalia Wasserstein; Marilena Skyllouriotou; Morris Strauss; Silvia Geron; Noa Sadan; Shifra Levartovsky; Rachel Sarig
Journal:  Int J Environ Res Public Health       Date:  2020-09-13       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.